标题
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-06-07
DOI
10.3389/fimmu.2019.01312
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner
- (2019) Dmytro Royzman et al. Frontiers in Immunology
- CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
- (2018) Ziduo Li et al. HAEMATOLOGICA
- CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell–Mediated CD4 T Cell Responses
- (2018) Kuan Y. Wong et al. JOURNAL OF IMMUNOLOGY
- The levels of soluble forms of CD21 and CD83 in multiple sclerosis
- (2018) Sajad Karampoor et al. JOURNAL OF NEUROIMMUNOLOGY
- CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
- (2018) Ziduo Li et al. HAEMATOLOGICA
- Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells
- (2018) Wei Lin et al. Frontiers in Immunology
- A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission
- (2018) Jennifer L. Hsu et al. OncoImmunology
- Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+Monocytes
- (2017) Joe M. Horvatinovich et al. JOURNAL OF IMMUNOLOGY
- Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing
- (2017) Sylvain Mareschal et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Crystal Structure of the Extracellular Domain of the Human Dendritic Cell Surface Marker CD83
- (2017) Christiane S. Heilingloh et al. JOURNAL OF MOLECULAR BIOLOGY
- NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis
- (2017) Wei Lin et al. Scientific Reports
- The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells
- (2017) Christiane S. Heilingloh et al. Frontiers in Microbiology
- A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice
- (2017) Katrin Regina Helene Packhäuser et al. Frontiers in Immunology
- Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83
- (2016) Julia von Rohrscheidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection
- (2016) Haiyin Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population
- (2016) Xinsheng Ju et al. JOURNAL OF IMMUNOLOGY
- CD83 Modulates B Cell Activation and Germinal Center Responses
- (2016) Lena Krzyzak et al. JOURNAL OF IMMUNOLOGY
- Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors
- (2016) Yang Cao et al. Oncotarget
- CD83 and GRASP55 interact in human dendritic cells
- (2015) Marcello F. Stein et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo
- (2015) Simon Kreiser et al. IMMUNOBIOLOGY
- L Particles Transmit Viral Proteins from Herpes Simplex Virus 1-Infected Mature Dendritic Cells to Uninfected Bystander Cells, Inducing CD83 Downmodulation
- (2015) Christiane S. Heilingloh et al. JOURNAL OF VIROLOGY
- Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation
- (2015) T A Seldon et al. LEUKEMIA
- Continuous expression of CD83 on activated human CD4+ T cells is correlated with their differentiation into induced regulatory T cells
- (2015) LIWEN CHEN et al. Molecular Medicine Reports
- Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells
- (2015) Yuetsu Tanaka et al. Retrovirology
- Recurrent targets of aberrant somatic hypermutation in lymphoma
- (2015) Alireza Hadj Khodabakhshi et al. Oncotarget
- Acute graft-versus-host disease: a bench-to-bedside update
- (2014) S. G. Holtan et al. BLOOD
- Soluble CD83 inhibits human monocyte differentiation into dendritic cells in vitro
- (2014) Hongyu Lin et al. CELLULAR IMMUNOLOGY
- CD83 Expression in CD4 + T Cells Modulates Inflammation and Autoimmunity
- (2014) Simone Reinwald et al. JOURNAL OF IMMUNOLOGY
- Soluble CD83 ameliorates experimental colitis in mice
- (2014) J Eckhardt et al. Mucosal Immunology
- Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis
- (2014) J M Bates et al. Mucosal Immunology
- The Expression and Characterization of Functionally Active Soluble CD83 by Pichia pastoris Using High-Density Fermentation
- (2014) Yugang Guo et al. PLoS One
- Soluble human CD83 ameliorates lupus in NZB/W F1 mice
- (2013) Charlotte Starke et al. IMMUNOBIOLOGY
- Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival
- (2013) F. Bock et al. JOURNAL OF IMMUNOLOGY
- Multiple Interferon Regulatory Factor and NF- B Sites Cooperate in Mediating Cell-Type- and Maturation-Specific Activation of the Human CD83 Promoter in Dendritic Cells
- (2013) M. F. Stein et al. MOLECULAR AND CELLULAR BIOLOGY
- Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas
- (2012) G. D. Victora et al. BLOOD
- How I treat relapsed and refractory Hodgkin lymphoma
- (2011) J. Kuruvilla et al. BLOOD
- CD83+ dendritic cells and Foxp3+ regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer
- (2011) Seigo Kashimura et al. Gastric Cancer
- Activated T cells induce rapid CD83 expression on B cells by engagement of CD40
- (2011) Birte Kretschmer et al. IMMUNOLOGY LETTERS
- CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation
- (2011) Lina E. Tze et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2
- (2011) L. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eukaryotic expression of functionally active recombinant soluble CD83 from HEK 293T cells
- (2010) Christine Staab et al. IMMUNOBIOLOGY
- Induction of Kidney Allograft Tolerance by Soluble CD83 Associated With Prevalence of Tolerogenic Dendritic Cells and Indoleamine 2,3-Dioxygenase
- (2010) Zhu Lan et al. TRANSPLANTATION
- Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection
- (2010) Wei Ge et al. TRANSPLANTATION
- Prevention of Chronic Renal Allograft Rejection by Soluble CD83
- (2010) Zhu Lan et al. TRANSPLANTATION
- CD83 polymorphisms and cervical cancer risk
- (2009) Kelly J. Yu et al. GYNECOLOGIC ONCOLOGY
- Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
- (2009) John Wilson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Engagement of CD83 on B Cells Modulates B Cell Function In Vivo
- (2009) B. Kretschmer et al. JOURNAL OF IMMUNOLOGY
- Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia
- (2009) B.D. Hock et al. LEUKEMIA RESEARCH
- Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas
- (2008) Minh Quang Huynh et al. LEUKEMIA & LYMPHOMA
- The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo
- (2008) M. Lechmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD83 regulates lymphocyte maturation, activation and homeostasis
- (2008) Minka Breloer et al. TRENDS IN IMMUNOLOGY
- Dendritic cell CD83: A therapeutic target or innocent bystander?
- (2007) Charlene M. Prazma et al. IMMUNOLOGY LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More